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Abstract
Physiologic osteoclastogenesis entails activation of multiple signal transduction pathways distal to the cell membrane
receptor RANK. However, atypical osteoclastogenesis driven by pro-inflammatory stimuli has been described. We have
reported recently a novel mechanism whereby endogenous mutational activation of the classical NF-kB pathway is
sufficient to induce RANKL/RANK-independent osteoclastogenesis. Here we investigate the physiologic relevance of this
phenomenon in vivo. Using a knock-in approach, the active form of IKK2, namely IKK2SSEE, was introduced into the myeloid
lineage with the aid of CD11b-cre mice. Phenotypic assessment revealed that expression of IKK2SSEE in the myeloid
compartment induced significant bone loss in vivo. This observation was supported by a dramatic increase in the number
and size of osteoclasts in trabecular regions, elevated levels of circulating TRACP-5b, and reduced bone volume.
Mechanistically, we observed that IKK2SSEE induced high expression of not only p65 but also p52 and RelB; the latter two
molecules are considered exclusive members of the alternative NF-kB pathway. Intriguingly, RelB and P52 were both
required to mediate the osteoclastogenic effect of IKK2SSEE and co-expression of these two proteins was sufficient to
recapitulate osteoclastogenesis in the absence of RANKL or IKK2SSEE. Furthermore, we found that NF-kB2/p100 is a potent
inhibitor of IKK2SSEE-induced osteoclastogenesis. Deletion of p52 enabled more robust osteoclast formation by the active
kinase. In summary, molecular activation of IKK2 may play a role in conditions of pathologic bone destruction, which may be
refractory to therapeutic interventions targeting the proximal RANKL/RANK signal.
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Introduction
Bone metabolism is tightly regulated by the actions of
osteoblasts and osteoclasts throughout life [1]. Whereas osteoblasts
are characterized as bone forming cells laying down organic
matrix, the primary function of osteoclasts is resorbing and
remodeling bones. Under physiologic conditions a balance regu-
lating bone formation and bone resorption is maintained.
Specifically, mesenchymal cells secrete factors such as RANK
ligand and osteoprotegerin to maintain and regulate osteoclast
formation and survival. However, under pathologic conditions the
delicate balance between bone formation and bone resorption is
disrupted contributing to many bone disorders [2,3].
Osteoclast differentiation entails binding of RANK ligand to its
cognate receptor on myeloid progenitor cells and subsequent
activation of multiple intracellular pathways including AKT/
PI3K, MAP kinase, and NF-kB [4]. The critical role of NF-kBi n
osteoclast differentiation and bone homeostasis has been widely
investigated [5,6]. This ubiquitous pathway controls physiologic
and pathologic responses in various tissues and encompasses
several critical kinases and signaling molecules with varying
degrees of contribution to tissue health and disease [7,8]. These
proteins have been classified into canonical and non-canonical
NF-kB pathways. The former pathway which is activated by
RANK ligand as well as by inflammatory stimuli such as TNF and
IL-1b, is regulated by the IKK complex dominated by IKK2 and
IKKc/NEMO leading to phosphorylation of IkB and activation
of p50, p65, cRel transcriptional complexes. On the other hand,
the non-canonical NF-kB pathway is regulated by NF-kB-
inducing kinase (NIK) which in turn activate IKK1 leading to
proteolytic processing of the inhibitory protein p100 and releasing
p52 and RelB, the downstream effectors of this pathway [9].
Genetic studies have shown that all members of canonical and
non-canonical NF-kB pathway are crucial for normal skeletal
development and bone health. In this regard, deletion of IKK1
[10], IKK2 [11,12], NEMO (unpublished data and [13]), NIK,
p52/p50, p65, RelB, and cRel resulted with impaired osteoclast
differentiation and/or function and abnormal skeletal develop-
ment [14–16].
Despite the exclusive role of RANK ligand as the master
regulator of physiologic osteoclastogenesis and bone homeostasis,
alternative pathways distinct from RANK ligand signaling
affecting osteoclastogenesis and bone metabolism have been
described. These include primarily pathologic stimulators, chiefly
TNF. In this regard, it has been demonstrated that aside from its
RANKL-costimulatory osteoclastogenic function, TNF induces
osteoclast formation in RANK/RANKL-deficient mice, in vivo,
albeit in the absence of NF-kBp100 subunit [17]. More recently,
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(IKK2 in which serines 177/181 were substituted with glutamates;
namely IKK2SSEE) induces osteoclastogenesis independent of
upstream RANK/RANKL and TNF/TNFr signaling [18]. This
constitutively active IKK2-dependent osteoclastogenesis was also
independent of IKK1, and NEMO. In this study, we show that
expression of IKK2SSEE in the myeloid compartment induces
significant bone loss in vivo. This observation is supported by
a significant increase in the number and size of osteoclasts in
trabecular regions, elevated levels of circulating TRACP-5b, and
reduced bone volume. Mechanistically, we report the novel finding
that IKK2SSEE activates RelB and p52, two components of the
non-canonical NF-kB pathway. More importantly, RelB and P52
are both required to mediate the osteoclastogenic effect of
IKK2SSEE and co-expression of these two proteins is sufficient
to recapitulate osteoclastogenesis.
Results
IKK2SSEE transgenic mice (IKK2SSEE
MYELO) display severe
bone loss
We have shown previously that the active form of IKK2,
IKK2SSEE, induces RANKL-independent osteoclastogenesis, in
vitro [18]. To determine the physiological significance of this
finding, we examined its role in vivo through expression of
constitutively active IKK2 in a tissue-specific manner. Specifically,
we employed the R26StopIKK2SSEE mice in which a cDNA
encoding IKK2 containing two serine to glutamate substitutions in
the activation loop of the kinase domain, preceded by a loxP-
flanked STOP cassette, was cloned into the ubiquitously expressed
ROSA26 locus [19]. We crossed mice carrying this allele to the
CD11b-cre mice in order to express IKK2SSEE exclusively in
myeloid cells, inclusive of osteoclast progenitors. Mice were born
and survived an average of 6 weeks of age. The IKK2SSEE
transgenic mice (herein referred to as IKK2SSEE
MYELO)
exhibited growth retardation and severe skin inflammation
(fig. 1A). Both macrophages and osteoclasts derived from
IKK2SSEE
MYELO express Flag-tagged IKK2SSEE detected by
western blot (fig. 1B). Histological (fig. 2), micro-CT and
histomorphometric (fig. 3) analyses showed that IKK2SSEE
MYELO
transgenic mice have significantly less trabecular bone compared
with the wild type (WT) mice, while no significant reduction of
cortical bone was observed (not shown). Specifically, bone mineral
density (BMD) in transgenic mice was 58.9% of that in WT mice.
BV/TV values were 0.177 mm3/mm3 in WT compared to
0.068 mm3/mm3 in transgenic mice. Closer examination re-
vealed that trabecular bone sections of IKK2SSEE transgenic
mice contain more and larger osteoclasts attached to trabeculi
(fig. 2, insert). Indeed, histomorphometric quantification using
Osteomeasure (Osteometrics, Inc) revealed that the trabecular
region of transgenic mice contains nearly twice as much osteoclasts
compared with WT mice (fig. 3). Supporting a functional
significance of this observation, IKK2SSEE
MYELO transgenic
mice have two-fold increase of serum TRACP 5b activity (fig. 4)
(10.59 U/L vs 4.93 U/L), reflecting an overall heightened bone
resorptive activity of osteoclasts in these mice.
Bone marrow macrophages derived from IKK2SSEE
transgenic mice undergo spontaneous differentiation into
osteoclasts. To determine the osteoclastogenic potential of
IKK2SSEE transgenic bone marrow macrophages, these cells
were cultured in vitro with M-CSF alone. Consistent with its
intrinsic osteoclast effect in vitro, IKK2SSEE-expressing bone
marrow macrophages isolated from these transgenic mice were
capable of forming osteoclasts ex-vivo in the absence of RANKL
(fig. 5). Furthermore, real-time PCR showed that IKK2SSEE
upregulated NFATc1 expression in macrophage/osteoclast line-
age (fig. 6). IKK2SSEE also significantly enhanced expression of
major osteoclast markers including TRAP, Cathepsin K, MMP9
and calcitonin receptor expression compared to the wild type
control (fig. 6).
Figure 1. Generation of IKK2SSEE
MYELO -tg mice. We utilized the
R26StopIkk2SSEE mice in which a cDNA encoding IKK2 containing two
serine to glutamate substitutions in the activation loop of the kinase
domain, preceded by a loxP-flanked STOP cassette, was cloned into the
ubiquitously expressed ROSA26 locus. We crossed mice carrying this
allele with the CD11b-cre mice in order to express IKK2SSEE exclusively
in myeloid cells, including osteoclasts and osteoclast precursors
(IKK2SSEE
MYELO –tg). A) Photograph of 2-week old wild type (WT) and
transgenic (TG) mice. B) Western blot detection of Flag-IKK2SEE (using
anti-Flag antibody) from corresponding bone marrow lysates.
doi:10.1371/journal.pone.0038694.g001
Figure 2. Decreased trabecular bone volume and increased
osteoclasts in IKK2SSEE
MYELO -tg mice. Tibia from wild type (WT)
and transgenic mice (TG) were histologically processed and stained
with tartrate-resistant acid phosphatase to detect osteoclasts. Top
panels display the growth plate and the proximal diaphysis regions.
Double-headed arrows indicate the trabecular region. Insert is
magnification (406) of trabecular region from WT and TG sections
showing giant osteoclasts (red) engulfing trabeculi. Images are
representative of five different experiments.
doi:10.1371/journal.pone.0038694.g002
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(RANKL and OPG) and inflammatory factors in
IKK2SSEE
MYELO mice
To explore the mechanism underlying enhanced osteoclast
activity in IKK2SSEE
MYELO-tg mice, we measured circulating
levels of osteoclastogenic factors (RANKL and OPG) and
inflammatory factors (TNFa and IL1b) which function coopera-
tively with RANKL. Serum level of RANKL and TNFa remain
normal, however serum levels of IL1b increased significantly
compared to wild type counterparts (fig. 7). Interestingly, serum
level of OPG also increased dramatically, probably reflecting
compensatory role of OPG in IKK2SSEE
MYELO -tg mice. To
determine if elevated levels of IL-1b are responsible for the
IKK2SSEE osteoclastogenic effect, IKK2SSEE transgenic mice
were cross bred with IL-1r knockout mice. However, all
parameters of osteoclastogenesis examined in these hybrid mice
were similar to those derived from the IKK2SSEE
MYELO-tg mice
(not shown).
IKK2SSEE induces osteoclastogenesis via activation of
NF-kB alternative pathway. We have shown previously that
IKK2SSEE induces expression of RelA/p65 (canonical pathway)
Figure 3. Bone mineral density is reduced in IKK2SSEE
MYELO -tg mice. Long bones of 4-week old wild type (9 mice) and transgenic (8) mice
were processed and analyzed by micro CT scanning as described under methods. Absolute values of bone mineral density (BMD), trabecular number
(Tb.N), trabeculat thickness (Tb.Th), number of osteoclasts per bone surface (N.Oc/BS) and bone volume/total volume (BV/TV) between WT and TG
mice are depicted. *P,0.05.
doi:10.1371/journal.pone.0038694.g003
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cells [18]. Consistent with these findings, we now show that
expression of these NF-kB subunits is also elevated in cells derived
from IKK2SSEE transgenic mice (Fig. 8A), suggesting that one or
a combination of these subunits maybe responsible for the
osteoclastogenic effect of IKK2SSEE. Thus, we surmised that
expression of these NF-kB subunits at various combinations may
recapitulate the IKK2SSEE osteoclastogenic effect. To this end,
expression of RelA, RelB, or p52 individually did not alter the
RANKL-independent osteoclastogenic potential of the cells, as
was the case when RelA and RelB were co-expressed (not shown).
Surprisingly, however, co-expression of p52 and RelB, both of
which are components of the non-canonical NF-kB activation
pathway (normally induced by IKK1), elicited RANKL-indepen-
dent osteoclastogenesis, in vitro (fig. 8B, panel A, and correspond-
ing images in fig. 8C). To determine if indeed p52 and RelB
subunits are essential mediators of this osteoclastogenic process, we
used P52-KO and p52/RelB double knockout cells. The results
depicted in figure 8B (panels B–C) show that whereas IKK2SSEE
induced robust osteoclastogenesis in p52 null cells expressing RelB
(fig. 8B, panel B), suggesting that NF-kB2/p100 is an endogenous
inhibitor of IKK2SSEE, combined deletion of p52NF-kB and
RelB abrogated the IKK2SSEE osteoclastogenic effect (gray bar).
To further verify the specificity of this event, the osteoclastogenic
effect of IKK2SSEE was examined using bone marrow macro-
phages isolated from IKK1-null cells. Supporting a specific
IKK2SSEE effect, combined expression of p52 and RelB NF-kB
subunits in IKK1-null cells mimicked IKK2SSEE-induced
osteoclastogenesis (fig. 8B, panel D). Taken together, the data
provides strong correlation between IKK2SSEE and P52/RelB-
induced osteoclastogenesis. To further determine if this evidence
holds true in the transgenic mouse model, IKK2SSEE-TG mouse
was crossed with the RelB germ line knockout mouse. Marrow
macrophages derived from the hybrid mouse, termed TG/RB-
KO, were subjected to siRNA knockdown of either P52 or P65/
RelA NF-kB subunits (siP52, siP65). Control conditions were
treated with scrambled sequence (si-scr) or vehicle. Cells were then
cultured in the presence of M-CSF, and osteoclasts were
determined in 6 day old culture using TRAP staining assay. The
results summarized in figure 8D indicate that whereas deletion of
RelB reduced osteoclasts by approximately 31%, combined
elimination of P52 (by siRNA knockdown) and RelB (by genetic
deletion) significantly abrogated the IKK2SSEE-TG osteoclasto-
genic effect (,87% reduction compared with TG control). On the
other hand, knockdown of P65 subunit in the RelB-KO
background had little effect on IKK2SSEE-TG-induced osteo-
clastogenesis. Altogether, our findings support the notion that p52
and RelB are the primary mediators of the IKK2SSEE
osteoclastogenic effect in vitro and in vivo.
Discussion
We published previously that the constitutively active form of
IKK2, namely IKK2SSEE, induces RANKL-independent osteo-
clastogenesis [18]. We also have established that deletion of the
IKK2 gene in the myeloid compartment impedes osteoclastogen-
esis [11]. In the current study, we examined the endogenous
osteoclastogenic role of IKK2SSEE. Restricted myeloid expression
of the IKK2SSEE transgene led to severe bone loss primarily in
the trabecular compartment. Further examination revealed an
increased number and size of osteoclasts corresponding with
elevated serum levels of TRACP5b in IKK2SSEE transgenic mice
compared with control counterparts. These results suggest that
activating mutations in the IKK2SSEE are sufficient to induce an
osteolytic disease.
Further support for the cell-autonomous intrinsic osteoclasto-
genic effect of IKK2SSEE stems from our observation that this
phenomenon appears to be independent of the osteoclastogenic
and inflammatory factors TNFa and IL1b. Although levels of the
latter cytokine were elevated under IKK2SSEE conditions,
deletion of IL1R and TNFr1 failed to alter the osteoclastogenic
effect of IKK2SSEE, suggesting that TNF and IL-1b are
dispensable for this phenomenon, and thus are presumed non-
essential mediators of this process. These findings are further
supported by our observation that retroviral transduction of
Figure 4. Serum levels of TRACP5b are elevated in IKK2SSEE-
MYELO -tg mice. Serum was collected from wild type (9) and transgenic
(8) mice and levels of the enzyme TRACP5b (U/L +/2SE) were
measured. * denotes p,0.05.
doi:10.1371/journal.pone.0038694.g004
Figure 5. Bone marrow macrophages derived from IKK2SSEE-
MYELO -tg mice generate RANKL-independent osteoclasts.
Marrow macrophages were isolated from wild type and IKK2SSEE
MYELO
-tg mice and cultured with M-CSF in the absence or presence of RANKL
(50 ng/ml). Cultures were fixed on day 5 of culture and stained with
TRAP. Purple/red cells are TRAP-positive bona fide osteoclasts which are
capable of resorbing bone (data not shown). Number of osteoclasts per
well (Average of 4 wells from 5 different experiments (+/2SE):
WT+RANKL 215+/232; TG 105+/217; TG+RANKL 248+/241.
doi:10.1371/journal.pone.0038694.g005
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RANKL-independent osteoclastogenesis in vitro (data not shown).
Altogether, these findings document uncoupling of the IKK2S-
SEE-induced inflammatory and osteoclastogenic events. However,
the functional significance of this finding remains to be in-
vestigated.
The most intriguing finding of our study was induction of RelB
and p52 expression by IKK2SSEE, two NF-kB subunits
traditionally induced by IKK1 and considered exclusive mediators
of the non-canonical NF-kB pathway. Consistent with this result,
co-expression of RelB and p52 subunits, but not individually,
induced osteoclastogenesis independent of RANKL and IKK1.
This observation suggests that these two non-canonical NF-kB
subunits concomitantly mediate the osteoclastogenic effect of
IKK2SSEE. The finding that IKK2SSEE and RelB/p52-induced
osteoclastogenesis ensues in the absence of the RANKL cytokine
and the IKK1gene presents a potential novel mechanism whereby
an IKK2SSEE/RelB/p52 signaling axis is sufficient to mediate
osteolysis. This proposition is further enforced by the fact that cells
lacking both RelB and p52 subunits fail to generate meaningful
osteoclasts when transduced with IKK2SSEE. In agreement with
this phenomenon, several reports established cross-talk and
Figure 6. Markers of osteoclast are increased in cells derived from IKK2SSEE
MYELO -tg mice. Bone marrow macrophages were isolated
from WT and IKK2SSEE-tg mice and cultured in the presence of M-CSF for 4 days. RNA was then extracted and subjected to real-time Q-PCR to detect
expression of the indicated markers. p,0.01 for NFATc1, p,0.01for TRAP, p,0.05 for Cathepsin K, p,0.01 for MMP9, and p,0.01 for calcitonin
receptor (CTR).
doi:10.1371/journal.pone.0038694.g006
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in different responses [20–22]. In this regard, it has been shown
that TNF, acting through the classical NF-kB pathway, up-
regulates RelB expression in human umbilical vein endothelial
cells [22]. In our case, we presume that direct activation of the
non-canonical effectors, RelB and P52, by IKK2SSEE may
represent uncoupling of the pro-inflammatory and pro-osteoclas-
togenic effects of constitutively active IKK2 in marrow macro-
phages.
Our study provides evidence for distinct osteoclastogenic events
emanating from RANKL signaling and IKK2SSEE. Whereas
RANKL induces osteoclastogenesis presumably through activation
of multiple coordinated pathways, the IKK2SSEE osteoclasto-
genic signal is rather restricted to NF-kB-dependent transcription.
Although the outcome of both processes appears similar, there is
mild morphological difference between RANKL and IKK2SSEE-
generated osteoclasts in culture. This variance could be related to
differences in cell adhesion, motility, or cytoskeletal arrangement.
Nevertheless, despite this change, IKK2SSEE-derived osteoclasts
are fully functional in vitro and in vivo. In other studies, it has
been shown that whereas IKK1 is required for RANKL-induced
osteoclastogenesis, it is dismissible for TNF and IL-1b-induced
osteoclastogenesis [12,23,24]. In fact, IKK1-null progenitors fail to
differentiate into osteoclasts in response to RANKL in vitro yet
they form osteoclasts in response to inflammatory stimuli including
TNF and IL-1 [12]. Our findings suggest that although RANKL,
TNF, and IL1b induce osteoclastogenesis through many signaling
pathways, IKK2SSEE appears to do so independently. Thus,
multiple osteoclastogenic pathways unique to RANKL, TNF, IL-
1b, and IKK2SSEE may exist. The biological significance of each
pathway remains obscure and may rely on the unique transcrip-
tional signature each transmits. In the case of IKK2SSEE, the
transcriptional complex contains at least RelB and p52 subunits.
In summary, we have identified a unique and novel cross-talk
between the canonical and non-canonical NF-kB pathway which
appears sufficient to induce osteoclast formation in vitro and bone
loss in vivo. This phenomenon is cell-autonomous and indepen-
dent of RANKL and IKK1. Future studies will attempt to verify
the transcriptional signature of this event.
Materials and Methods
Reagents
P65, P50 and P52 antibodies were purchased from Cell
Signaling Technology (Danvers, MA). Polyclonal anti- RelB
antibody was purchased from Santa Cruz Biotechnology Inc
(Santa Cruz, CA). Monoclonal anti b-actin and polyclonal anti-
Flag antibodies were obtained from Sigma-Aldrich (St. Louis,
MO).
Generation of mice
We used R26StopIkk2SSEE mice in which a cDNA encoding
IKK2 containing two serine to glutamate substitutions in the
activation loop of the kinase domain, preceded by a loxP-flanked
STOP cassette, was cloned into the ubiquitously expressed
ROSA26 locus [19]. We crossed mice carrying this allele to the
CD11b-cre mice in order to express IKK2SSEE exclusively in
myeloid cells (osteoclast progenitors). Both macrophages and
osteoclasts derived from CD11bCre/R26StopIKK2SSEE express
Flag-tagged IKK2SSEE detectable by Western blot.
Mouse osteoclasts
Bone marrow macrophages were isolated from long bones of 6-
to 8-week-old mice as described previously [11]. Osteoclasts were
generated by culturing bone marrow macrophages with RANKL
(50 ng/ml) and M-CSF (10 ng/ml) for 4–5 days, or by in-
troduction of pMx-IKK2SSEE retroviral particles into marrow
macrophages and culturing with M-CSF for 4–5 days.
Plasmids and retrovirus generation
IKK2SSEE, P52, RelB were cloned into the pMx retroviral
vector fused with either HA or FLAG. To generate retrovirus,
PLAT-E cells, which stably express retroviral packaging genes,
were transfected with expression vector by using transient
transfection reagent. Viral supernatants were collected on day 2
and day 3 post-transfection and immediately used to infect freshly
isolated bone marrow macrophages. After 24 h, medium contain-
ing the appropriate selection (2 mg/ml puromycin or 1 mg/ml
blasticidin) was added to cells for 48 h to select for virus-expressing
cells.
Western blot analysis
Bone marrow macrophages or osteoclasts starved for 6 hours in
serum-free medium were stimulated with RANKL (50 ng/ml) and
M-CSF (10 ng/ml) and lysed at the times indicated (per
experimental conditions) in RIPA lysis buffer supplemented with
protease inhibitors and sodium orthovanadate. Equal amount of
total cell lysate from each condition was loaded subjected to SDS-
PAGE electrophoresis and immunoblots.
Cytokine measurements
Serum levels of RANKL, OPG, TNF, and IL-1b were
measured using commercial ELISA kits (R&D systems, Minnea-
polis, MN) and following manufacturer’s instructions.
Real-time PCR
Total RNA was isolated from cell cultures at various times using
the RNeasy Mini Kit (Qiagen) and was reverse transcribed to
cDNAs using SuperScript II according to the manufacturer’s
instructions (Invitrogen). Primers specific for murine NFATc1,
TRAP, GAPDH, cathepsin K, and calcitonin receptor were used.
For quantitative real-time PCR, NFATc1 was amplified using 59-
CCCGTCACATTCTGGTCCAT-39 and 59-CAAG-
Figure 7. Expression levels of IL-1b and OPG are higher in the
serum of IKK2SSEE
MYELO -tg mice. IL-1b, OPG, RANKL and TNFa
levels in the serum of wild type and transgenic mice were measured
using commercial ELISA kits. * denotes p,0.05 (IL-1b) and p,0.05
(OPG).
doi:10.1371/journal.pone.0038694.g007
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59-CAGCTCCCTAGAAGATGGATTCAT-39 and 59-GTCAG-
GAGTGGGAGCCATATG-39; cathepsin K using 59-
ATGTGGGTGTTCAAGTTTCTGC-39 and 59-CCACAA-
GATTCTGGGGACTC-39; and calcitonin receptor using 59-
CAAGAACCTTAGCTGCCAGAG-39 and 59-CAAG-
CACGCGGACAATGTTG-39; GAPDH using 59-
TGTGTCCGTCGTGGATCTGA-39and 59-CCTGCTTCAC-
CACCTTCTTGA -39. SYBR green dye was used for detection
of the product using the SYBR Green PCR Master Mix assay
(Applied Biosystems). The standard curve used series of duplicate
dilutions of plasmid for each gene and b-actin cDNA. The
amplification reaction was performed for 40 cycles with de-
naturation at 95uC for 10 minutes, followed by annealing at 95uC
for 15 seconds and extension and detection at 60uC for 1 minute.
The relative RNA abundance of each target gene transcript was
normalized against endogenous gene control.
siRNA knockdown
siRNA oligos were purchased from Thermo Scientific Dhar-
macon and used to achieve gene knockdown in marrow
macrophage cultures. Cells were plated in 6-well tissue culture
plates. After one day, cells were transfected with 10 ul of X-treme
siRNA transfection reagents (Roche, Indianapolis, IN) and 10 ul
of pooled 5 uM siRNA oligos (Thermo Scientific Dharmacon,
Lafayette, CO) according to manufacturer’s protocol. Cells were
further cultured for 5 days and TRAP-stained or lysed for Western
blot assays.
Figure 8. NF-kB subunits RelB and p52 mediate the osteoclastogenic effect of IKK2SSEE. A) Marrow macrophages were isolated from WT
and IKK2SSEE transgenic (TG) mice and plated in culture for 5 days in the presence of M-CSF. One set of WT cells was treated with RANKL (to serve as
a positive control). Total cell lysates were subjected to Western blots as indicated. B) Marrow macrophages were isolated from mice with the
indicated gene deletions (denoted by genotype at the lower part of the figure). Cells were infected with retrovirus expressing the indicated gene
products (denoted by retrovirus) and were cultured with M-CSF in the absence of RANKL. Cell cultures were fixed and TRAP-stained on day 5. Multi-
nucleated ($3 nuclei/cells) TRAP-positive cells were counted from three different wells for each condition. The data represent the average of three
independent experiments. *p,0.01, **p,0.05. C) Representative images of osteoclast cultures depicted in fig. 8B. D) IKK2SSEE transgenic mice alone
or crossed with RelB-KO mice (hybrid denoted TG/RB-KO) were used. Osteoclasts were generated (in the absence of RANKL) from marrow
macrophages isolated from IKK2SSEE-transgenic mice and from hybrid TG/RB-KO mice. In addition, osteoclasts were generated from marrow
macrophages isolated from the latter mouse in which either P52-NF-kB or RelA were silenced using siRNA approach. Bottom panels of 8C are western
blots for p52 and p65 (RelA) from control (scr=scramble) and silenced (si) conditions. Knockdown efficiency exceeded 80% of control.
doi:10.1371/journal.pone.0038694.g008
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Intact limbs were preserved in 10% buffered formalin (24 h),
skinned, and subjected to a decalcification process using 10%
EDTA, pH 7.0, for 7 days with gentle rocking and daily
replacement of solution. Decalcified bones were then dehydrated
in graded alcohol, cleared through xylene, and embedded in
paraffin. Paraffin blocks were sectioned longitudinally. Five-
micron sections were then stained with hematoxylin and eosin
or histochemically with tartrate-resistant acid phosphatase (TRAP)
to determine osteoclasts.
Micro-Computed Tomography (mCT)
Mouse bones were scanned using microCT (mCT 40, Scanco
Medical, Switzerland). The proximal metaphysis regions of tibias
were scanned to assess trabecular bone morphology (with the
following parameters: 55 kVp, 145 mA, standard resolution, 16.4-
mm diameter, 16-mm voxel size, 300-ms integration time). The
area of interest was identified just distal to the growth plate and
spans a height of 480 mm (30 slices). Following the manufacturer’s
3D analysis tools, we measured bone mineral density (BMD),
fraction of bone volume known as bone volume over total volume
(BV/TV), trabecular thickness (Tb.Th), trabecular separation
(Tb.Sp), and trabecular number (Tb.N).
Statistical analysis
Experiments were repeated at least three times. Changes were
assessed using paired t tests. Statistically significant differences
were considered at p,0.05. In relevant experiments, we used 6–9
mice per group to achieve statistical significance based on
expected effect size of 25%.
All animals are housed in the facility at Washington University
under the care of trained technicians and veterinarians. Animals
experiencing pain or discomfort following procedures are treated
with analgesics per approved protocol. Euthanasia is performed by
inhalation of gaseous CO2 in a closed chamber. This method is
approved by the AVMA. All animal work was pre-approved by
the animal committee of Washington University and conducted
according to AVMA guidelines.
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